Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

John M. Murray; Kristin McBride; Christoph Boesecke; Michelle Bailey; Janaki Amin; Kazuo Suzuki; David Baker; John J. Zaunders; Sean Emery; David A. Cooper; Kersten K. Koelsch; Anthony D Kelleher

doi:10.1097/qad.0b013e328350fb3c

journal article Mar 13, 2012

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

John M. Murray Kristin McBride Christoph Boesecke Michelle Bailey Janaki Amin Kazuo Suzuki David Baker

John J. Zaunders

Sean Emery David A. Cooper

Kersten K. Koelsch Anthony D Kelleher

AIDS Vol. 26 No. 5 pp. 543-550 · Ovid Technologies (Wolters Kluwer Health)

View at Publisher Save 10.1097/qad.0b013e328350fb3c

Topics

No keywords indexed for this article. Browse by subject →

References

26

[1]

Chun "Latent reservoirs of HIV: obstacles to the eradication of virus." Proc Natl Acad Sci USA (1999) 10.1073/pnas.96.20.10958

[2]

Pomerantz "Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication." Clin Infect Dis (2002) 10.1086/338256

[3]

Shen "Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection." J Allergy Clin Immunol (2008) 10.1016/j.jaci.2008.05.033

[4]

Trono "HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals." Science (2010) 10.1126/science.1191047

[5]

Perelson "Decay characteristics of HIV-1-infected compartments during combination therapy." Nature (1997) 10.1038/387188a0

[6]

Palmer "Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy." Proc Natl Acad Sci USA (2008) 10.1073/pnas.0800050105

[7]

Chun "Early establishment of a pool of latently infected, resting CD4() T cells during primary HIV-1 infection." Proc Natl Acad Sci USA (1998) 10.1073/pnas.95.15.8869

[8]

Finzi "Latent infection of CD4 T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy." Nat Med (1999) 10.1038/8394

[9]

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

Mark E. Sharkey, Ian Teo, Thomas Greenough et al.

Nature Medicine 2000 10.1038/71569

[10]

Murray "Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase." AIDS (2007) 10.1097/qad.0b013e3282f12377

[11]

Markowitz "Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study." J Acquir Immune Defic Syndr (2007) 10.1097/qai.0b013e318157131c

[12]

Koelsch "Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir." AIDS (2011) 10.1097/qad.0b013e32834b9658

[13]

Palmer "New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma." J Clin Microbiol (2003) 10.1128/jcm.41.10.4531-4536.2003

[14]

Suzuki "Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region." J RNAi Gene Silencing (2005)

[15]

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Nicolas Chomont, Mohamed El-Far, Petronela Ancuta et al.

Nature Medicine 2009 10.1038/nm.1972

[16]

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection

Audrey Brussel, Dominique Mathez, Sophie Broche-Pierre et al.

AIDS 2003 10.1097/00002030-200303280-00001

[17]

Hazuda "Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells." Science (2000) 10.1126/science.287.5453.646

[18]

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Nicolas Chomont, Mohamed El-Far, Petronela Ancuta et al.

Nature Medicine 2009 10.1038/nm.1972

[19]

Hatano "Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals." AIDS (2010) 10.1097/qad.0b013e32833dba03

[20]

Agosto "Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs." Virology (2011) 10.1016/j.virol.2010.08.024

[21]

Graf "Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV patients on and off HAART." PLoS Pathog (2011) 10.1371/journal.ppat.1001300

[22]

Sharkey "In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA." J Virol (2005) 10.1128/jvi.79.8.5203-5210.2005

[23]

Pierson "Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication." J Virol (2002) 10.1128/jvi.76.8.4138-4144.2002

[24]

Butler "Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles." J Virol (2002) 10.1128/jvi.76.8.3739-3747.2002

[25]

Koelsch "Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro." J Infect Dis (2008) 10.1086/525283

[26]

HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

Maria J Buzón, Marta Massanella, Josep M Llibre et al.

Nature Medicine 2010 10.1038/nm.2111

Cited By

61

HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy

Guillaume J. Besson, Christina M. Lalama · 2014

Clinical Infectious Diseases

Metrics

61

Citations

26

References

Details

Published: Mar 13, 2012
Vol/Issue: 26(5)
Pages: 543-550

Authors

for the CHAMP Trial Group Investigators

Department of Biochemistry, University of Washington, Seattle, WA 98105;; Institute for Protein Design, University of Washington, Seattle, WA 98105;; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98105

J

John J. Zaunders

St. Vincent's Centre for Applied Medical Research, Darlinghurst, NSW, Australia

S

Sean Emery

The Kirby Institute, University of New South Wales, Sydney, NSW, Australia

The Kirby Institute, University of New South Wales, Sydney, NSW, Australia

A

Anthony D Kelleher

The Kirby Institute of New South Wales, Sydney, Australia; St Vincent's Centre for Applied Medical Research, Sydney, Australia

Cite This Article

John M. Murray, Kristin McBride, Christoph Boesecke, et al. (2012). Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards. AIDS, 26(5), 543-550. https://doi.org/10.1097/qad.0b013e328350fb3c

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

You May Also Like